ReviewCirculation. Cardiovascular quality and outcomes2022
Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association.
Review in Circulation. Cardiovascular quality and outcomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 26 citations in OpenAlex.
- Comparative effectiveness of non-reflective and reflective strategies to favor de-implementation of low-value prescribing for the primary prevention of cardiovascular disease in primary care: the DE-imFAR cluster randomized implementation trial.Implementation science communications · 2026Article
- Artificial Intelligence Powered Wearable and Portable Devices for Remote Cardiac Care and Population Health.Current cardiology reports · 2026Review
- Evaluation of Payer Policies to Reduce Low-Value Medical Device-Based Procedure Use.JAMA health forum · 2025Article
- The triglyceride-glucose index: updating evidence from clinical settings to molecular mechanisms in ageing-related cerebrovascular diseases.Cardiovascular diabetology · 2025Review
- Associations of Chinese diagnosis-related group system with low-value coronary revascularisation: an interrupted time series analysis.BMJ open · 2025Observational
- Artificial Intelligence-Enhanced Risk Stratification of Cancer Therapeutics-Related Cardiac Dysfunction Using Electrocardiographic Images.Circulation. Cardiovascular quality and outcomes · 2025Article
- Optimizing Cardiovascular Assessment: Reducing Unnecessary Cardiac Troponin I Testing.Global heart · 2025Article
- Association of a Novel Electronic Form for Preoperative Cardiac Risk Assessment With Reduction in Cardiac Consultations and Testing: Retrospective Cohort Study.JMIR perioperative medicine · 2024Article
- Validity of an Administrative Claims-Based Measure of Low-Value Preoperative Cardiac Stress Testing.Circulation. Cardiovascular quality and outcomes · 2024Article
- Residual Chest Pain After PCI: A Failure in Diagnosis Rather Than Treatment.Journal of the American College of Cardiology · 2024Article
- Routine Functional Testing or Standard Care in High-Risk Patients after Percutaneous Coronary Intervention.Current cardiology reports · 2024Review
- Validity of an Administrative Claims-Based Measure of Low-Value Carotid Revascularization.Journal of the American Heart Association · 2024Article
- Evolution of Value in American College of Cardiology/American Heart Association Clinical Practice Guidelines.Circulation. Cardiovascular quality and outcomes · 2023Article
- Prioritizing Quality Measures in Acute Stroke Care : A Cost-Effectiveness Analysis.Annals of internal medicine · 2023Article
- Leveling the playing field: The utility of coronary artery calcium scoring in cardiovascular risk stratification in South Asians.American journal of preventive cardiology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Low-value health care services that provide little or no benefit to patients are common, potentially harmful, and costly. Nearly half of the patients in the United States will receive at least 1 low-value test or procedure annually, creating risk of avoidable complications from subsequent cascades of care and excess costs to patients and society. Reducing low-value care is of particular importance to cardiovascular health given the high prevalence and costs of cardiovascular disease in the United States. This scientific statement describes the current scope and impact of low-value cardiovascular care; reviews existing literature on patient-, clinician-, health system-, payer-, and policy-level interventions to reduce low-value care; proposes solutions to achieve meaningful and equitable reductions in low-value care; and suggests areas for future research priorities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.